Immunopathogenic mechanisms of type 1A diabetes mellitus (DM-1A);Imunopatogenéza diabetes mellitus 1A (DM-1A)

Cesko-Slovenska Pediatrie

Volumn 57, Issue 6, 2002, Pages 299-305

  Buc, Milan ^a   Shawkatova I ^a  

^a Faculty of Natural Sciences   (Slovakia)

Author keywords

Cytokines; DM 1A; HLA complex; NKT cells; T lymphocytes; Viruses

Indexed keywords

EID: 0038893792     PISSN: 00692328     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Alt, F., Marrack, P. (Eds.): Autoimmunity. Curr. Op. Immunol., 12, 2000, č. 6, s. 661-738.
2. Bendelac, A., Bonneville, M., Kearney, J. F.: Autoreactivity by design: innate B and T lymphocytes. Nature Rev. Immunol., 2, 2001, č. 3, s. 177-186.
3. Benoist, Ch., Mathis, D.: Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry. Nature Immunol., 2, 2001, č. 9, s. 797-801.
4. Bottazzo, G., Mirakian, R., Drexhage, H. A.: Adrenalitis, oophoritis and autoimmune polyglandular disease. In: Clinical Immunology. Principles and Practice (Ed. Rich, R. R.), s. 1523-1550. St. Louis, Boston, New York, Philadelphia, London, Sydney, Tokyo, Mosby 1996. 2228 s.
5. Buc, M.: HLA komplex v biológii a medicíne. Bratislava, Veda 1989. 184 s.
6. Buc, M.: Klinická imunológia. Bratislava, Veda 1997. 363 s.
7. Buc, M.: Imunológia. Bratislava, Veda 2001. 463 s.
8. Bušová, B., Michalková, D., Buc, M.: Segregácia HLA-haplotypov s inzulín-dependentným diabetes mellitus (IDDM) - rodinné štúdie. Klin. imunol. Alergol., 5, 1995, č. 4, s. 11-15.
9. Cinek, O., Koloušková, S., Šnajderová, M. et al.: HLA class II genetic association of type I diabetes mellitus in Czech children. Pediat. Diabetes, 2, 2001, s. 98-102.
10. Cooke, A., Phillips, M., Parish, N.M.: Tolerogenic strategies to halt or prevent type I diabetes. Nature Immunol., 2, 2001, č. 2, s. 810-815.
11. Elson, Ch. J., Barker, R. N.: Helper T cells in antibody-mediated, organ-specific autoimmunity. Curr. Op. Immunol., 12, 2000, č. 6, s. 664-669.
12. Ettinger, R. A., Nepom, G. T.: Molecular aspects of HLA class II αβ heterodimers associated with IDDM susceptibility and protection. Rev. Immunogen., 2, 2000, č. 1, s. 88-94.
13. Harrison, L. C., Schmidli, R. S., Petrovsky, N. et al.: Insulin-dependent diabetes. In: Clinical Immunology. (Ed. Bradley, J., McCluskey, J.). Oxford, New York, Melbourne, Oxford University Press 1997. 572 s.
14. Chowdhury, T. A., Kumar, T. A., Mijovic, C. H., Barnett, A. H.: The aetiology of type I diabetes. Bailliers Best Pract. Res. Clin. Endocrinol. Metabol., 13, 1999, č. 2, s. 181-195.
15. Kotzin, B. L.: Mechanisms of autoimmunity. In: Clinical Immunology. Principles and Practice (Ed. Rich, R. R.), s. 58.1-58.13. London, Edinburg, New York, Philadelphia, St. Louis, Sydney, Toronto, Mosby 2001.
16. Kukreja, A., Maclaren, N. K.: Autoimmunity and diabetes. J. Clin. Endocrinol. Metab., 84, 1999, č. 12, s. 4371-4378.
17. Lee, K. H., Wucherpfennig, K. W., Wiley, D. C.: Structure of a human insuline peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes. Nature Immunol., 2, 2001, č. 6, s. 501-507.
18. Maloy, K. J., Powrie, F.: Regulatory T cells in the control of immune pathology. Nature Immunol., 2, 2001, č. 9, s. 816-822.
19. Markham, A., Lamb, H. M.: Infliximab. A review of its use in the management of rheumatoid arthritis. Drug, 59, 2000, č. 6, s. 1341-1359.
20. Martinka, E.: Úskalia klasifikácie diabetes mellitus. Bratislava, Lufema 1999. 176 s.
21. Martinka, E., Shawkatová, I., Bue, M. et al.: Latent autoimmune (type 1) diabetes mellitus in patients classified originally as type - 2 diabetes. In: Proceedings of the 10th Int. Congress of Immunol., New Delhi 1998, s. 1211-1216.
22. McCormack, R. M., Maxwell, A. P., Carson, D. et al.: Possible association between CTLA4 DNA polymorphism and early onset type 1 diabetes in a UK population. Genes & Immunity, 2, 2001, č. 4, s. 233-235.
23. Nepom, G. T.: HLA and type I diabetes. In: HLA in Health and Disease. (Eds. Lechler, R., Warrens, A.). 2nd ed. San Diego, San Francisco, New York, Boston, London, Sydney, Tokyo, Academic Press 2000. 472 s.
24. Peterson, P., Nagamine, K., Scott, H. et al.: APECED: a monogenic autoimmune disease providing new clues to self-tolerance. Immunol. Today, 19, 1998, č. 9, s. 384-386.
25. Rosmalen, J. G. M., van Ewijk, W., Leenen, P. J. M.: T cell education in autoimmune diabetes: teachers and students. Trends Immunol., 23, 2002, č. 1, s. 40-46.
26. Sakaguchi, S.: Animal models of autoimmunity and their relevance to human diseases. Curr. Op. Immunol., 12, 2000, č. 6, s. 684-690.
27. Sharif, S., Arreaza, G. A., Zucker, P. et al.: Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes. Nature Med., 7, 2001, č. 9, s. 1057-1062.
28. Shawkatová, I.: Štúdium vzt'ahu HLA-komplexu k diabetes mellitus a potransplantačného chimérizmu pomocou analýzy DNA. Doktorandská dizertačná práca. Bratislava, Lekárska fakulta UK 2000. 101 s.
29. Singh, B., Delovitch, T. L.: Immune mechanisms that regulate susceptibility to autoimmune type I diabetes. Clin. Rev. Allergy Immunol., 9, 2000, č. 3, s. 247-264.
30. Thomas, J. W., Powers, A. C.: Immunology of diabetes. In: Clinical Immunology. Principles and Practice (Ed. Rich, R. R.), s. 1503-1521. 1st ed. St. Louis, Boston, New York, Philadelphia, London, Sydney, Tokyo, Mosby 1995. 2228 s.
31. Robles, D. T., Eisenbarth, G. S.: Diabetes and related autoimmune diseases. In: Clinical Immunology. Principles and Practice (Ed. Rich, R. R.), s. 82.1-82.18. London, Edinburg, New York, Philadelphia, St. Louis, Sydney, Toronto, Mosby 2001.
32. Undlien, D. E., Thorsby, E.: HLA association in type 1 diabetes: merging genetics and immunology. Trends Immunol., 22, 2001, č. 9, s. 467-469.
33. Wang, B., Geng, Y. B., Wang, C. R.: CD1 restricted NKT cells protect nonobese diabetic mice from developping diabetes. J. exp. Med., 194, 2001, č. 3, s. 313-320.
34. Wills-Kaarp, M., Santeloiz, J., Karp, Ch. L.: The germless theory of allergic diseases: revisiting the hygiene hypothesis. Nature Rev. Immunol., 1, 2001, č. 1, s. 69-75.
35. Virella, G., Goust, J. M.: Organ-specific autoimmune diseases. In: Medical Immunology (Ed. Virella, G.). New York, Basel, Marcel Dekker 2001, s. 341-376.
36. Wu, Q., Salomon, B., Chen, M. et al.: Reversal of spontaneous autoimmune insulitis in nonobese diabetic mice by soluble lymphotoxin receptor. J. exp. Med., 193, 2001, č. 11, s. 1327-1332.
37. Wucherpfennig, K. W., Eisenbaarth, G. S.: Type I diabetes. Nature Immunol., 2, 2001, č. 2, s. 767-768.